Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02258464
Title Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NOR | NLD | ISR | IRL | GBR | FRA | FIN | ESP | DNK | DEU | CZE | CHE | CAN | AUT

Facility Status City State Zip Country Details
Bakersfield California 93309 United States Details
La Jolla California 92093 United States Details
Aurora Colorado 80045 United States Details
New Haven Connecticut 06520 United States Details
Cedar Rapids Iowa 52403 United States Details
Annapolis Maryland 21401 United States Details
Ann Arbor Michigan 48109 United States Details
Pontiac Michigan 48341 United States Details
Saint Louis Missouri 63110 United States Details
Pittsburgh Pennsylvania 15213-3180 United States Details
Houston Texas 77230 United States Details
Linz Oberösterreich 4020 Austria Details
Innsbruck 6020 Austria Details
Winnipeg Manitoba R3E 0V9 Canada Details
London Ontario N6A 4L6 Canada Details
Newmarket Ontario L3Y 2P9 Canada Details
Toronto Ontario M5G 2M9 Canada Details
Ostrava 708 52 Czechia Details
Praha 2 12808 Czechia Details
Copenhagen 2100 Denmark Details
Herlev 2730 Denmark Details
Helsinki 00290 Finland Details
Tampere FIN-33520 Finland Details
Angers Cedex 49055 France Details
Saint Cloud 92210 France Details
Tübingen Baden-Württemberg 72076 Germany Details
Bonn Nordrhein-Westfalen 53105 Germany Details
Essen Nordrhein-Westfalen 45147 Germany Details
Kowloon Hong Kong Details
Cork Ireland Details
Dublin 7 Ireland Details
Afula 1834111 Israel Details
Haifa 3109601 Israel Details
Jerusalem 9103102 Israel Details
Jerusalem 9112001 Israel Details
Kfar Saba 4428164 Israel Details
Ramat Gan 5262000 Israel Details
Tel Aviv 64239 Israel Details
Zerifin 7030000 Israel Details
Busan 49241 Korea, Republic of Details
Daegu 42601 Korea, Republic of Details
Incheon Korea, Republic of Details
Seoul 03080 Korea, Republic of Details
Seoul 05505 Korea, Republic of Details
Seoul 120-752 Korea, Republic of Details
Nieuwegein 3435 CM Netherlands Details
Zwolle 8025 AB Netherlands Details
Oslo 0424 Norway Details
Bialystok 15-027 Poland Details
Gdynia 81-519 Poland Details
Warszawa 02-781 Poland Details
Singapore 119074 Singapore Details
L'Hospitalet de Llobregat Barcelona 08907 Spain Details
A Coruña 15009 Spain Details
Barcelona 08025 Spain Details
Barcelona 08036 Spain Details
Madrid 28033 Spain Details
Madrid 28040 Spain Details
Madrid 28041 Spain Details
Málaga 29010 Spain Details
Sevilla 41071 Spain Details
Zaragoza 50009 Spain Details
Aarau Aargau 5001 Switzerland Details
Taipei 11217 Taiwan Details
Plymouth Devon PL6 8DH United Kingdom Details
Northwood Middlesex HA6 2RN United Kingdom Details
Nottingham Nottinghamshire NG5 1PB United Kingdom Details
Taunton Somerset TA1 5DA United Kingdom Details
Cottingham HU16 5JQ United Kingdom Details
Merseyside CH63 4JY United Kingdom Details
Sheffield S10 2SJ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field